1172058

Ayman Gaballah, M.D. — FEI 3022034550

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
June 10, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Columbia, MO (United States)

Additional Details

Clinical Investigator (CI)